Diagnostic bronchoscopy is effective as a tool for patients with COPD

Performing Procedures

Is Diagnostic Bronchoscopy Safe in Patients with COPD?

“Given the high and rising global burden of COPD, a revolution in the diagnosis and management of COPD and exacerbations of COPD in low and middle income countries must be an urgent priority.”

Diagnostic bronchoscopy is an effective tool for patients with chronic obstructive pulmonary disease (COPD) and its related diseases, according to a new systematic review and meta-analysis.

“The major complication rate of diagnostic bronchoscopy in patients with COPD was acceptable and low,” write Dr. Congcong Li and others in a study out of China published in Expert Review of Respiratory Medicine.

Because COPD is a major risk factor for lung cancer and infection and often coexists with other diseases, there was concern that the weaker status of those patients could lead to more serious complications when bronchoscopy was performed.

COPD refers to a group of diseases that cause airflow blockage and breathing problems for an estimated 16 million Americans who suffer from the affliction, according to the Centers for Disease Control and Prevention. (CDC).

The research examined 18 trials and found the major complication rate of bronchoscopy to be about 4.3 percent. Patients experiencing a COPD flareup showed a higher complication rate of 7.8 percent. The use of sedative medicine also was related to more complications, the authors write.

These findings “reminded us to be more cautious when conducting bronchoscopies in this patient population,” the researchers add.

COPD was the fourth-leading cause of death in the U.S. in 2018, based on the most current statistics available.

As baby boomers age, COPD has become a growing problem, and respiratory therapists are increasingly taking on the role of COPD navigators who help patients get proper treatment, along with education and follow up care to try to prevent additional flareups of the disease.

Worldwide, COPD is expected to become the leading cause of death by 2033, according to doctors S.A. Quaderi and J.R. Hurst in the “Unmet Global Burden of COPD” in Global Health, Epidemiology and Genomics.

“Given the high and rising global burden of COPD, a revolution in the diagnosis and management of COPD and exacerbations of COPD in low and middle income countries (LMICs) must be an urgent priority,” those authors write.

More Pulmonology Articles
Respiratory Care Week 2022: The Future of Respiratory Care
Respiratory Care Week
The American Association for Respiratory Care (AARC) has devised a strategic plan to nurture workforce recovery, promote diversity, equity and inclusion, and to reimagine its brand. We talk to its executive director about these initiatives.
APIC: It’s Time to Reevaluate Infection Preventionists’ Workload
Preventing Infection
Given the unrelenting waves of the novel coronavirus, it is vital to make sure IPs can focus on patient safety and infection monitoring rather than paperwork, the Association for Professionals in Infection Control and Epidemiology says.
More From Single-Use Endoscopy
What is the ‘Holiday Effect’ on ERCPs?

Gastrointestinal Endoscopy Procedure

Researchers have found certain post-ERCP complications to be more frequent in December. But why?

Medicare penalties for high readmissions are lower than they have been, but still affect nearly 2,300 U.S. hospitals.

Value-Based Care

Lowering readmission rates remains a national priority for payers, providers and policymakers seeking to improve healthcare while reducing costs.

Our Top 5 Urology Storylines of the Fall

Public Health

Reprocessed urological endoscopes, emerging technology, and the environmental impact of single-use endoscopes were some of the themes of our most-read stories on Single-Use Endoscopy.